Ladenburg, Germany, 13 March 2025 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech Company developing innovative Antibody Drug Conjugates (ADCs), and HealthCare Royalty (HCRx) today ...
ContractHeidelberg Pharma Amends Royalty Financing with HealthCare Royalty 13-March-2025 / 00:31 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, ...
For older women, menopausal hormone therapy (HT) use is associated with faster regional tau accumulation, accordin ...
Korea JoongAng Daily on MSN1dOpinion
Is overeating really a form of addiction?No food has such an overpowering level of addictiveness. It is time to move beyond the misuse of the word “addiction” in ...
DAVID SWARTZ, Director at RadNet RDNT , reported an insider sell on March 12, according to a new SEC filing. What Happened: SWARTZ's decision to sell 25,000 shares of RadNet was revealed in a Form 4 ...
Crediting Prime Minister Narendra Modi and Union Health Minister JP Nadda, Himachal Pradesh Bharatiya Janata Party (BJP) chief Rajeev Bindal on Wednesday hailed the All India Institute of Medical ...
This is the third indication under clinical development for soquelitinib, which is also in a registrational Phase 3 trial for peripheral T cell lymphoma (PTCL) and a Phase 1 trial for atopic ...
Medical Imaging Corp. (OTCMKTS:MEDD – Get Free Report)’s share price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.00 and traded as ...
Presenting their top academic honors for 2025, the Academic Senate and Federation recognize and showcase faculty not just for ...
Teddi Mellencamp was diagnosed with melanoma in 2022. Since then, she's had multiple biopsies, surgeries and the cancer has ...
Since the donation of a SPECT camera by the International Atomic Energy Agency (IAEA), a busy hospital in Brazil’s city of Niteroi has doubled its capacity to perform heart scans, expanding access to ...
Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback